[Event: ASCO] Jen-Tang Lu of Vysioneer

from Microdosing · host Paul Schrimpf

Jen-Tang Lu of Vysioneer shares shares how they are using AI to unlock real-world guideline-based tumor response assessments, and improve clinical trials in that space.

Episode metadata supplied by the publisher feed · Published Jun 4, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

[Event: ASCO] Jen-Tang Lu of Vysioneer

0:00 6:08

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Microdosing?

This episode is 6 minutes long.

When was this Microdosing episode published?

This episode was published on June 4, 2022.

Can I download this Microdosing episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!